In Vitro Diagnostics Market (Clinical Chemistry, Immunoassay, Diabetes Testing, Blood Testing, Molecular Diagnostics) - Global Industry Analysis, Forecasts, 2012-2018
London (PRWEB) October 16, 2013 -- In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of body and therefore are very essential to take well-informed medical decisions. This report estimates the market for the in vitro diagnostics terms of revenue (USD million) for the period 2012 – 2018, keeping 2011 as the base year.
The in vitro diagnostics market is segmented into two major types namely market by geography and market by products. The market estimation for the U.S. and two emerging economies (China and India) have also been included in the report.
The U.S., India and China in vitro diagnostics market is segmented by products into clinical chemistry IVDs, Immunoassay IVDs, diabetes testing IVDs, blood testing IVDs, molecular diagnostics, and other IVDs. The global market for in vitro diagnostics is segmented on the basis of geography into North America, Europe, Asia-Pacific and rest of the world (RoW) regions and this market is provided in terms of USD million.
This report includes the market shares of key players in 2011. Moreover, company profiles for some of the key players are included in the report in terms of company overview, financial overview, business strategies, recent developments and product portfolio. The major companies included in the report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.
The global in vitro diagnostics market is categorized into the following segments:
Market by Products
U.S.
Clinical Chemistry
Immunoassay
Diabetes Testing
Blood Testing
Molecular Diagnostics
Others (Flow Cytometry, Microbiological Diagnostic Techniques)
India
Clinical Chemistry
Immunoassay
Diabetes Testing
Blood Testing
Molecular Diagnostics
Others (Flow Cytometry, Microbiological Diagnostic Techniques)
China
Clinical Chemistry
Immunoassay
Diabetes Testing
Blood Testing
Molecular Diagnostics
Others (Flow Cytometry, Microbiological Diagnostic Techniques)
Market by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Market Trend and Future Outlook
3.1.1 Global In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
3.2 Market Dynamics
3.2.1 Market drivers
3.2.1.1 Rising Number of Patients with Infectious and Chronic Diseases
3.2.1.2 Increasing Global Healthcare Expenditure
3.2.1.3 Demand for Rapid and Minimally- or Non-Invasive Diagnostic Tools & Techniques
3.2.1.4 Impact Analysis of the Market Drivers
3.2.2 Market Restraints
3.2.2.1 Reimbursement Challenges Retards the Growth of Market
3.2.2.2 Uncertain and Ambiguous Regulatory environment restrains In Vitro Diagnostics market
3.2.2.3 Impact Analysis of the Market Restraints
3.2.3 Market Opportunities
3.2.3.1 Molecular Diagnostics: Key to Future
3.2.3.2 Epigenomics-Based Diagnostics expected to be an Emerging segment in In-Vitro Diagnostic Market
3.2.4 Porter’s Five Forces Analysis for In Vitro Diagnostic Market
3.2.4.1 Bargaining Power of Suppliers
3.2.4.2 Bargaining Power of Buyers
3.2.4.3 Threat of new entrants
3.2.4.4 Threat of substitutes
3.2.5 Competitive rivalry
3.3 Market Attractiveness Analysis of the Global In-Vitro Diagnostics Market, by Geography
Chapter 4 Global In Vitro Diagnostics Market, by Products (Qualitative information)
4.1 Overview
4.2 Clinical Chemistry
4.3 Immunoassay
4.4 Diabetes Testing
4.5 Blood Testing
4.6 Molecular Diagnosis
4.7 Others
Chapter 5 Global In Vitro Diagnostics Market, by Geography
5.1 Overview
5.2 North America
5.2.1 North America In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.3 Europe
5.3.1 Europe In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific In Vitro Diagnostics Market, 2010-2018 (USD Million)
5.5 Rest of the World
5.5.1 ROW In Vitro Diagnostics Market, 2010-2018 USD Million)
Chapter 6 U.S. In Vitro Diagnostics Market, by Products
6.1 Overview
6.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
6.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
6.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
6.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
6.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
6.7 Others IVD Market, 2010 – 2018 (USD Million)
Chapter 7 China In Vitro Diagnostics Market, by Products
7.1 Overview
7.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
7.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
7.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
7.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
7.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
7.7 Others IVD Market, 2010 – 2018 (USD Million)
Chapter 8 India In Vitro Diagnostics Market, by Products
8.1 Overview
8.2 Clinical Chemistry IVD Market, 2010 – 2018 (USD Million)
8.3 Immunoassay IVD Market, 2010 – 2018 (USD Million)
8.4 Diabetes Testing IVD Market, 2010 – 2018 (USD Million)
8.5 Blood Testing IVD Market, 2010 – 2018 (USD Million)
8.6 Molecular Diagnosis IVD Market, 2010 – 2018 (USD Million)
8.7 Others IVD Market, 2010 – 2018 (USD Million)
Chapter 9 Competitive Landscape
9.1 Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)
Chapter 10 Company Profiles
10.1 Abbott Laboratories Inc.
10.1.1 Company Overview
10.1.2 Financial overview
10.1.3 Business Strategies
10.1.4 Product Portfolio
10.1.5 Recent Developments
10.2 Alere, Inc.
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Business Strategies
10.2.4 Product Portfolio
10.2.5 Recent Developments
10.3 Bayer AG
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Business Strategies
10.3.4 Product Portfolio
10.3.5 Recent Developments
10.4 Becton, Dickinson and Company
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Business Strategies
10.4.4 Product Portfolio
10.4.5 Recent Developments
10.5 Biomerieux SA
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Business Strategies
10.5.4 Product Portfolio
10.5.5 Recent Developments
10.6 Beckman Coulter, Inc.
10.6.1 Company Overview
10.6.2 Financial overview
10.6.3 Business Strategies
10.6.4 Product portfolio
10.6.5 Recent developments
10.7 Gen-Probe Incorporated
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Business Strategies
10.7.4 Product Portfolio
10.7.5 Recent Developments
10.8 Johnson and Johnson
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Business Strategies
10.8.4 Product Portfolio
10.8.5 Recent Developments
10.9 Life Technologies Corporation
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Business Strategies
10.9.4 Product Portfolio
10.9.5 Recent Developments
10.10 F. Hoffmann-La Roche Ltd
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Business strategies
10.10.4 Product portfolio
10.10.5 Recent developments
10.11 Siemens Healthcare
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Business Strategies
10.11.4 Product Portfolio
10.11.5 Recent Developments
10.12 Thermo Fisher Scientific, Inc.
10.12.1 Company Overview
10.12.2 Financial overview
10.12.3 Business strategies
10.12.4 Product portfolio
10.12.5 Recent developments
List of Figures
FIG. 1 Market Segmentation for the In Vitro Diagnostics Market
FIG. 2 Global In Vitro Diagnostics Market, U.S., 2011 (USD Million)
FIG. 3 Global In Vitro Diagnostics Market, China., 2011 (USD Million)
FIG. 4 Global In Vitro Diagnostics Market, India, 2011 (USD Million)
FIG. 5 Global In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
FIG. 6 Total Healthcare Expenditure, Per Capita ( in USD)
FIG. 7 Porter’s Five Forces Analysis for In Vitro Diagnostic Market
FIG. 8 Market Attractiveness Analysis of the Microscopy Devices Market, by geography
FIG. 9 Comparative Analysis of the Global IVD Market, by Geography, 2011 & 2018 (%)
FIG. 10 N. America In Vitro Diagnostics Market , 2010 – 2018 (USD Million)
FIG. 11 Europe In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
FIG. 12 Asia Pacific In Vitro Diagnostics Market, 2010 – 2018 (USD Million)
FIG. 13 RoW In Vitro Diagnostics Market, U.S., 2010 – 2018 (USD Million)
FIG. 14 Comparative Analysis of the U.S. In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
FIG. 15 Clinical Chemistry IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 16 Immunoassay IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 17 Diabetes IVD Market, U.S., Market, 2010 – 2018 (USD Million)
FIG. 18 Blood Testing IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 19 Molecular Diagnosis IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 20 Other IVD Market, U.S., 2010 – 2018 (USD Million)
FIG. 21 Comparative Analysis of the China In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
FIG. 22 Clinical Chemistry IVD Market, China, 2010 – 2018 (USD Million)
FIG. 23 Immunoassay IVD Market, China, 2010 – 2018 (USD Million)
FIG. 24 Diabetes IVD Market, China, Market, 2010 – 2018 (USD Million)
FIG. 25 Blood Testing IVD Market, China, 2010 – 2018 (USD Million)
FIG. 26 Molecular Diagnosis IVD Market, China, 2010 – 2018 (USD Million)
FIG. 27 Other IVD Market, China, 2010 – 2018 (USD Million)
FIG. 28 Comparative Analysis of the Indian In Vitro Diagnostics Market, by Products, 2011 & 2018 (%)
FIG. 29 Clinical Chemistry IVD Market, India, 2010 – 2018 (USD Million)
FIG. 30 Immunoassay IVD Market, India, 2010 – 2018 (USD Million)
FIG. 31 Diabetes testing IVD Market, India, Market, 2010 – 2018 (USD Million)
FIG. 32 Blood Testing IVD Market, India, 2010 – 2018 (USD Million)
FIG. 33 Molecular Diagnosis IVD Market, India, 2010 – 2018 (USD Million)
FIG. 34 Other IVD Market, India, 2010 – 2018 (USD Million)
FIG. 35 Global In Vitro Diagnostics Market Share, by Key Players, 2011 (%)
FIG. 36 Annual Revenue of Abbott Laboratories Inc., Diagnostics Division, 2010 – 2012 (USD million)
FIG. 37 Annual Revenue of Alere Inc., 2009– 2011 (USD million)
FIG. 38 Annual Sales of Bayer Healthcare, a division of Bayer AG, 2010–2012 (USD million)
FIG. 39 Annual revenue of BD Company, 2010 – 2012 (USD million)
FIG. 40 Annual revenue of BioMerieux SA, 2010 – 2012 (USD million)
FIG. 41 Annual revenue of Beckman Coulter, Inc., 2009 – 2010 (USD million)
FIG. 42 Annual revenue of Gen-Probe, Inc., 2010 – 2012 (USD Million)
FIG. 43 Annual revenue of Johnson and Johnson, Medical Devices an d Diagnostics Segment , 2010 – 2012 (USD Million)
FIG. 44 Annual revenue of Life Technologies Corporation, 2010 – 2012 (USD Million)
FIG. 45 Annual revenue of Roche Diagnostics, division of Roche Holdings, 2010 – 2012 (USD Million)
FIG. 46 Annual Revenue of Siemens Healthcare, 2009–2011 (USD million)
FIG. 47 (Conversion rate: 1 Euro = 1.33 USD)
FIG. 48 Annual revenue of Thermo Fisher Scientific, Inc., 2010 – 2012 (USD million)
List of Tables
TABLE 1 Market Snapshot: Global In Vitro Diagnostics Market
TABLE 2 Impact Analysis of the Market Drivers for In-Vitro Diagnostics Market
TABLE 3 Impact Analysis of the Market Restraints for Stem Cells Market
TABLE 4 Global IVD Market, by Geography, 2010 – 2018 (USD Million)
TABLE 5 U.S. IVD Market, by Products, 2010 – 2018 (USD Million)
TABLE 6 China IVD Market, by Products, 2010 – 2018 (USD Million)
TABLE 7 Indian IVD Market, by Products, 2010 – 2018 (USD Million)
Read the full report:
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com
Sarah Smith, Research Advisor at Reportbuyer.com, +44 208 816 85 48, [email protected]
Share this article